单位：[1]Department of Ophthalmology, Peking University People’s Hospital Key Laboratory of Vision Loss and Restoration, Ministry of Education and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China[2]Department of Ophthalmology, People’s Liberation Army (PLA) Rocket Force General Hospital, Beijing, China[3]Department of Ophthalmology, Children’s Hospital of Nanjing Medical University, Nanjing, China[4]Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China
出处：
ISSN：
基金：
National Natural Science Foundation of China, Beijing, ChinaNational Natural Science Foundation of China (NSFC) [81271027]
第一作者单位：[1]Department of Ophthalmology, Peking University People’s Hospital Key Laboratory of Vision Loss and Restoration, Ministry of Education and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China[2]Department of Ophthalmology, People’s Liberation Army (PLA) Rocket Force General Hospital, Beijing, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Ophthalmology, Peking University People’s Hospital Key Laboratory of Vision Loss and Restoration, Ministry of Education and Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing, China[*1]Department of Ophthalmology, People’s Hospital, Peking University, 11 Xizhimen South Street, Xicheng District, 100044, Beijing, China
推荐引用方式(GB/T 7714)：
Feng Jing,Qian Jing,Jiang Yanrong,et al.Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China[J].OPHTHALMOLOGY.2017,124(3):408-409.
APA：
Feng, Jing,Qian, Jing,Jiang, Yanrong,Zhao, Mingwei,Liang, Jianhong...&Li, Xiaoxin.(2017).Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China.OPHTHALMOLOGY,124,(3)
MLA：
Feng, Jing,et al."Efficacy of Primary Intravitreal Ranibizumab for Retinopathy of Prematurity in China".OPHTHALMOLOGY 124..3(2017):408-409
医学